Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 2 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Recs

0
Player Avatar carlsbadkevin (< 20) Submitted: 7/16/2013 3:38:40 PM : Outperform Start Price: $44.03 LGND Score: -1.62

royalties plus a great pipeline

Featured Broker Partners


Advertisement